What is the ticker symbol for United Therapeutics Corporation?

The ticker symbol for United Therapeutics Corporation is NASDAQ:UTHR

Does United Therapeutics Corporation pay dividends?

No, United Therapeutics Corporation does not pay dividends

What sector is United Therapeutics Corporation in?

United Therapeutics Corporation is in the Healthcare sector

What industry is United Therapeutics Corporation in?

United Therapeutics Corporation is in the Specialty & Generic Drug Manufacturers industry

What country is United Therapeutics Corporation based in?

United Therapeutics Corporation is headquartered in United States

When did United Therapeutics Corporation go public?

United Therapeutics Corporation initial public offering (IPO) was on June 17, 1999

Is United Therapeutics Corporation in the S&P 500?

No, United Therapeutics Corporation is not included in the S&P 500 index

Is United Therapeutics Corporation in the NASDAQ 100?

No, United Therapeutics Corporation is not included in the NASDAQ 100 index

Is United Therapeutics Corporation in the Dow Jones?

No, United Therapeutics Corporation is not included in the Dow Jones index

When was United Therapeutics Corporation last earnings report?

United Therapeutics Corporation's most recent earnings report was on August 5, 2026

When does United Therapeutics Corporation report earnings?

The next expected earnings date for United Therapeutics Corporation is October 28, 2026

UTHR Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, UTHR price is $533.12, down -1.55% on October 16, 2026
Current Price All-Time High: UTHR price is currently -12.51% below its historical high of $609.35 set on May 6, 2026
Market Cap: UTHR current market cap is $23B, up +23.18% over the past 365 days
PE Ratio: UTHR current PE ratio is 19.07
Revenue: UTHR current annual revenue is $3.18B, up +10.61% year-over-year
Next Earnings: The next earnings release for UTHR is on October 28, 2026

Profile

Company profile for United Therapeutics Corporation (UTHR)
Metric	Value
Full Name	United Therapeutics Corporation
Ticker	NASDAQ: UTHR
Exchange	NASDAQ
Sector	Healthcare
Industry	Specialty & Generic Drug Manufacturers
Country	United States
IPO	Jun 17, 1999
Indexes	Not included
Website	unither.com
Employees	1,305

Key Metrics

United Therapeutics Corporation Key Details
Metric	Value	Date
Price	$533.12	Oct 16, 26
Price, 1D Change	-1.55%	Oct 16, 26
Market Cap	$23B	Oct 16, 26
	-	Oct 16, 26
PE Ratio	19.07	Oct 16, 26
Beta	0.24	Oct 16, 26
Revenue	$3.18B	Dec 31, 25
Revenue, 1Y Change	+10.61%	Dec 31, 25
EPS	$27.86	Dec 31, 25
EPS, 1Y Change	+13.08%	Dec 31, 25

Events

United Therapeutics Corporation Events
Metric	Value	Date
Next Earnings		Oct 28, 26
Last Qtr. Earnings		Aug 5, 26
Last Ann. Earnings		Feb 25, 26
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	2:1	Sep 23, 09
Next Split	N/A	N/A
Last Ticker Change	N/A	N/A
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

UTHR Estimates
Metric	Value	Date
EPS	$27.86	Dec 31, 25
EPS Estimate	$26.16	N/A
EPS Est. Change	-6.12%	N/A
Revenue	$3.18B	Dec 31, 25
Revenue Estimate	$3.16B	N/A
Revenue Est. Change	-0.74%	N/A
Current Price	$533.12	Oct 16, 26
Price Target	$692.50	-
Price Tgt. Change	+29.90%	-

🔒 Log In To Unlock Full Data

EPS

UTHR EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	$24.57	$24.64	+0.30%
2025	$26.95	$27.86	+3.41%
2026	$26.16	N/A	-6.12%
2027	$30.20	N/A	+8.38%

Revenue

UTHR revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$2.88B	$2.88B	+0.08%
2025	$3.20B	$3.18B	-0.55%
2026	$3.16B	N/A	-0.74%
2027	$3.54B	N/A	+11.25%

🔒 Log In To Unlock Full Data

Performance

UTHR Performance
Metric	Value	Date
Price, 1Y	+23.21%	Oct 16, 26
Price, 3Y	+128.91%	Oct 16, 26
Market Cap, 1Y	+23.18%	Oct 16, 26
Market Cap, 3Y	+108.98%	Oct 16, 26
Revenue, 1Y	+10.61%	Dec 31, 25
Revenue, 3Y	+64.37%	Dec 31, 25
EPS, 1Y	+13.08%	Dec 31, 25
EPS, 3Y	+85.81%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

UTHR Technical Indicators
Metric	Value	Date
Current Price	$533.12	Oct 16, 26
SMA 200	$527.00	Oct 16, 26
SMA 50	$514.66	Oct 16, 26
EMA 200	$510.08	Oct 16, 26
EMA 50	$522.39	Oct 16, 26
MACD	$9.62	Oct 16, 26
Beta	0.24	Oct 16, 26
ATR	$18.94	Oct 16, 26
14-Day RSI	53.10	Oct 16, 26
10-Day Volatility	24.18%	Oct 16, 26

Dividends

UTHR Dividends
Metric	Value	Date
	-	N/A
Upcoming	N/A	N/A
	-	Oct 16, 26
	-	Dec 31, 25
	$0.00	Dec 31, 25
	0.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

UTHR Income & Profitability
Metric	Value	Date
Revenue	$3.18B	Dec 31, 25
EPS	$27.86	Dec 31, 25
Gross Profit	$0.00	Dec 31, 25
Gross Margin	87.92%	Dec 31, 25
Operating Income	$1.52B	Dec 31, 25
Operating Margin	47.67%	Dec 31, 25
Net Income	$1.33B	Dec 31, 25
Net Margin	41.94%	Dec 31, 25
EBITDA	$1.60B	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

UTHR Financial Health
Metric	Value	Date
Debt To Equity	0.00	Dec 31, 25
	6.60	Dec 31, 25
	6.28	Dec 31, 25
	-	Dec 31, 25
	6	Jun 30, 26
	18.72	Oct 16, 26

Valuations

UTHR Valuations
Metric	Value	Date
PE Ratio	19.07	Oct 16, 26
	7.25	Oct 16, 26
	3.57	Oct 16, 26
	13.52	Oct 16, 26
	-	N/A

Balance Sheet

UTHR Balance Sheet
Metric	Value	Date
Book Value	$7.10B	Dec 31, 25
	$2.92B	Dec 31, 25
	$7.97B	Dec 31, 25
	$3.70B	Dec 31, 25
	$872.90M	Dec 31, 25
	$560.60M	Dec 31, 25
Total Debt	$0.00	Dec 31, 25
	$0.00	Dec 31, 25
	$7.10M	Dec 31, 25

Expenses

UTHR Expenses
Metric	Value	Date
	$1.85B	Dec 31, 25
	$1.28B	Dec 31, 25
	$384.40M	Dec 31, 25
	$0.00	Dec 31, 25
	$85.60M	Dec 31, 25
	$0.00	Dec 31, 25
	$379.20M	Dec 31, 25

Cash Flow

UTHR Cash Flow
Metric	Value	Date
	$1.56B	Dec 31, 25
	-$551.30M	Dec 31, 25
	-$1.15B	Dec 31, 25
Capex	$526.00M	Dec 31, 25
	$1.04B	Dec 31, 25

Recent analyst updates

UTHR Recent analyst updates
Metric	Value	Date
RBC Capital	→	Oct 8, 26
Morgan Stanley	→	Oct 7, 26
BTIG	→	Oct 1, 26
Goldman Sachs		Sep 24, 26
RBC Capital	→	Aug 6, 26
JP Morgan	→	Jul 23, 26
B of A Securities	→	Jul 10, 26
RBC Capital	→	Jul 7, 26
Wells Fargo	→	May 7, 26
RBC Capital	→	May 7, 26

Analyst sentiment

Institutional ownership

Screeners with UTHR

FAQ

What is the ticker symbol for United Therapeutics Corporation?: The ticker symbol for United Therapeutics Corporation is NASDAQ:UTHR
Does United Therapeutics Corporation pay dividends?: No, United Therapeutics Corporation does not pay dividends
What sector is United Therapeutics Corporation in?: United Therapeutics Corporation is in the Healthcare sector
What industry is United Therapeutics Corporation in?: United Therapeutics Corporation is in the Specialty & Generic Drug Manufacturers industry
What country is United Therapeutics Corporation based in?: United Therapeutics Corporation is headquartered in United States
When did United Therapeutics Corporation go public?: United Therapeutics Corporation initial public offering (IPO) was on June 17, 1999
Is United Therapeutics Corporation in the S&P 500?: No, United Therapeutics Corporation is not included in the S&P 500 index
Is United Therapeutics Corporation in the NASDAQ 100?: No, United Therapeutics Corporation is not included in the NASDAQ 100 index
Is United Therapeutics Corporation in the Dow Jones?: No, United Therapeutics Corporation is not included in the Dow Jones index
When was United Therapeutics Corporation last earnings report?: United Therapeutics Corporation's most recent earnings report was on August 5, 2026
When does United Therapeutics Corporation report earnings?: The next expected earnings date for United Therapeutics Corporation is October 28, 2026

Data Sources & References

UTHR Official Website www.unither.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1082554/000108255426000006/0001082554-26-000006-index.htm
UTHR Profile on Yahoo Finance finance.yahoo.com/quote/UTHR
UTHR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/uthr